Recent

% | $
Quotes you view appear here for quick access.

OCATA THERAPEUTICS, INC. Message Board

freddyaophelps 567 posts  |  Last Activity: 1 hour 39 minutes ago Member since: Apr 18, 2013
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • I suspect he lost a spam contract to have room for that many new aliases.

  • Reply to

    Who In their right mind would buy this?

    by itsinthe.water Mar 25, 2015 1:49 PM
    freddyaophelps freddyaophelps Mar 25, 2015 1:53 PM Flag

    We are witnessing the uncontrolled birthing of bashchimps! He's either lost a spam contract or started another yahoo account to have that many open alias slots.

    itsinthe.water
    2 posts
    Member since: Mar 25, 2015

    jim.dandy30
    1 post
    Member since: Mar 25, 2015

  • freddyaophelps freddyaophelps Mar 25, 2015 1:44 PM Flag

    jim.dandy30
    1 post |
    Member since: Mar 25, 2015

    Happy Birthday bashchimp!

  • freddyaophelps freddyaophelps Mar 25, 2015 1:19 PM Flag

    Does anyone need proof that Jack is right?

    keep_investing • Nov 20, 2014 4:12 PM
    Freddy, one reason we bashers work so hard...

    One sentence directly from the bashchimps mouth says it all so well.

  • Reply to

    Press Release : )

    by freddyaophelps Mar 24, 2015 9:07 AM
    freddyaophelps freddyaophelps Mar 25, 2015 10:47 AM Flag

    Ocata Announces Proof-of-Concept Results in Restoring Vision and Prevention of Blindness

    Ocata can now take advantage of induced and embryonic pluripotent stem cells to produce commercially viable human tissue for transplantation. We recently confirmed proof of concept in creating photoreceptors capable of preventing blindness and restoring vision in established animal models. Data from these studies will be published later this year.”

    : )

  • Reply to

    Press Release : )

    by freddyaophelps Mar 24, 2015 9:07 AM
    freddyaophelps freddyaophelps Mar 24, 2015 6:40 PM Flag

    MARLBOROUGH, Mass.-- Ocata Therapeutics, Inc. (“Ocata” or “the Company”; NASDAQ: OCAT), a leader in the field of Regenerative Ophthalmology™, today announced that it has entered into a definitive agreement with Allele Biotechnology & Pharmaceuticals, Inc. of San Diego, CA (“Allele”) to access Allele’s proprietary technology for generating human induced pluripotent stem cells (“iPSCs”).

    "This agreement with Allele is part of our strategy to broaden our technology platform and increase our leadership in regenerative ophthalmology,” said Paul Wotton Ph.D., President and CEO of Ocata. “Ocata can now take advantage of induced and embryonic pluripotent stem cells to produce commercially viable human tissue for transplantation. We recently confirmed proof of concept in creating photoreceptors capable of preventing blindness and restoring vision in established animal models. Data from these studies will be published later this year.”

    Since Dr. Yamanaka discovered how to generate iPSCs in 2007 there has been tremendous enthusiasm about the potential to use these pluripotent cells to develop commercially viable therapies. Despite many efforts to develop iPSC derived therapies in the same scalable and reliable way as embryonic stem cells, many of those efforts have been unsuccessful due to issues relating to the growth capacity, differentiation potentials and epigenetic properties of iPSCs. The “footprint-free” reprogramming technology developed by Allele potentially offers a reliable and scalable process for producing iPSCs with superior properties and is a major step for translation of iPSC technology to practical clinical use. These iPSCs can potentially be used to manufacture millions of treatment doses as off-the-shelf therapies for any patient.

    “We have had a strong leadership role in this area,” said Robert Lanza, M.D., Chief Scientific Officer of Ocata. “Ocata has extensive experience and patent rights in generating both ocular and non-ocular cell types from human iPSCs. We have painstakingly and patiently evaluated many different iPSC technologies and selected the Allele technology only after we were satisfied and confident that this represented the best of all approaches and could permit us to generate transplantable tissues that would be potentially safe in human patients. In our hands, the iPSCs we are generating are comparable to our embryonic stem cells in those features required for use in potential human therapies.”

    “It is particularly rewarding to us that Ocata, a company whose understanding of the science and regulatory requirements in this space is unparalleled, has selected the iPSC technology developed at Allele for application in its own pipeline,” said Jiwu Wang Ph.D., President and CEO of Allele. “It only serves to confirm our belief that our iPSC platform is a solution to what otherwise have been unresolved issues associated with the maturation of iPSCs to a fully functional state. The ability to predictably derive stable iPSC lines without using any viral element or foreign DNA enables both fundamental scientific research and clinical applications, which has been the mission of Allele Biotechnology from its inception.”

  • Reply to

    Q2 2015: Partnership of non-core assets

    by freddyaophelps Mar 3, 2015 4:59 PM
    freddyaophelps freddyaophelps Mar 24, 2015 6:16 PM Flag

    Odd how all the bashchimp aliases revert to the same nonsense when they get upset.
    Back to CCTR, you never owned it? You just randomly pick a stock, go to their board and say....buy?

    keep_investing • Feb 13, 2015 10:40 AM Flag
    Anyway just looking at the price history of CCTR is mind boggling, to say the very least...
    So buy yourself 1M shares...

  • Reply to

    Q2 2015: Partnership of non-core assets

    by freddyaophelps Mar 3, 2015 4:59 PM
    freddyaophelps freddyaophelps Mar 24, 2015 5:35 PM Flag

    No chimp, I'm doing fine, like I told your rainman alias this just another step for OCAT. How YOU doing on your CCTR junk? Got to be hard making any money there when only $40 worth traded today, why did you delete your CCTR posts

    : )

  • freddyaophelps freddyaophelps Mar 24, 2015 4:34 PM Flag

    blakes176
    12 posts |
    Member since: Oct 13, 2014

    They are easy to spot if you recognize the signs.
    : )

  • Reply to

    All you need to know about keep_investing-

    by freddyaophelps Feb 26, 2015 2:59 PM
    freddyaophelps freddyaophelps Mar 24, 2015 3:33 PM Flag

    Freddy, one reason we bashers work so hard...

    How many is "we" keepee?

  • Reply to

    Press Release : )

    by freddyaophelps Mar 24, 2015 9:07 AM
    freddyaophelps freddyaophelps Mar 24, 2015 3:07 PM Flag

    “Ocata can now take advantage of induced and embryonic pluripotent stem cells to produce commercially viable human tissue for transplantation."

    Did you read this drizzleboy?

    : )

  • freddyaophelps freddyaophelps Mar 24, 2015 2:58 PM Flag

    All his aliases revert to the same writing style. The question is how many is "ALL" ?

  • freddyaophelps freddyaophelps Mar 24, 2015 2:26 PM Flag

    rog 6 posts in 7 minutes, where do all their posts go?

    rog3328
    38 posts
    Member since: May 12, 2014

  • s.jet64
    14 posts
    Member since: Nov 5, 2014

  • "This agreement with Allele is part of our strategy to broaden our technology platform and increase our leadership in regenerative ophthalmology,” said Paul Wotton Ph.D., President and CEO of Ocata. “Ocata can now take advantage of induced and embryonic pluripotent stem cells to produce commercially viable human tissue for transplantation. We recently confirmed proof of concept in creating photoreceptors capable of preventing blindness and restoring vision in established animal models. Data from these studies will be published later this year.”

  • freddyaophelps freddyaophelps Mar 24, 2015 11:39 AM Flag

    father_merrin
    20 posts
    Member since: Feb 16, 2015

  • freddyaophelps freddyaophelps Mar 24, 2015 11:35 AM Flag

    freddyaophelps • Feb 2, 2015 12:34 PM .

    While we're on the subject of fidgety and gidgity...How about that MDBX "pop"? You remember when it had that computer glitch ghost cat bounce at $6 and you thought it really had gone to $9?.... You don't remember? It was really funny....price was still $6 but you came here to tell us it had gone up 50% with out verifying or trying to sell?... I know you deleted that post but maybe this will help you remember-

    asscandyandy • Jan 15, 2015 10:09 AM Flag
    Fweedy as Don calls you I'm here to help you grasshopper if you're unwilling to accept fine then so be it,on the infamous day you decreed so emphatically was in fact a glitch after checking for sure I did prematurely tought......
    -----------------------------------------

    MDBX $1.52 today"
    That's not twirling spamcan, that's getting impaled!....Should have listened to "Fweedy

  • Reply to

    Press Release : )

    by freddyaophelps Mar 24, 2015 9:07 AM
    freddyaophelps freddyaophelps Mar 24, 2015 11:26 AM Flag

    This isn't "huge" news, just another step to where we are going. I know it and so do you bashchimps. You clowns pump your junk stocks like NEWL, HKUP, MDBX, SKTO, CCTR etc and bash OCAT just like you did REGN and FSLR in the past. I assume you get paid for your efforts, nobody can be that wrong all the time.

    : )

  • freddyaophelps freddyaophelps Mar 24, 2015 11:05 AM Flag

    spamcanandy picked up that nasty disease from iHookUp, HKUP, made his wallet shrink to, A LOT! You don't even want to know what happened to him in MudBox, MDBX ! Look at the charts, they don't lie.

    Bwaaahahahaaaaahahaahha

  • freddyaophelps freddyaophelps Mar 24, 2015 10:08 AM Flag

    col_trautman11
    23 posts
    Member since: Mar 2, 2015

ACTC
6.97+0.17(+2.50%)Nov 13 3:59 PMEST